Latest 23andMe Inc. Stories
Erynn Gordon to Oversee Engagement with Medical Community and Key Clinical Applications as Medical Marketing Director MOUNTAIN VIEW, Calif., March 19, 2015
NEW YORK, March 16, 2015 /PRNewswire/ --Kalorama information suggests that the FDA approval of a rare gene test from Mountain View, Calif.-based personal genetics company 23andMe will open the
First ever genome-wide association study on common, incurable skin condition pinpoints two genetic variants associated with rosacea MOUNTAIN VIEW, Calif., March 10, 2015 /PRNewswire/
Privacy and Health Information Technology Expert Joins 23andMe Leadership Team MOUNTAIN VIEW, Calif., Feb.
BRONX, N.Y., Feb.
23andMe's Personal Genome Service® 510(k) Submission for Bloom Syndrome Carrier Status Test Report Granted Marketing Authority through De Novo Classification MOUNTAIN VIEW, Calif.,
First ever genome-wide association study on motion sickness links 35 genetic variants to the condition; some variants display stronger effects in women MOUNTAIN VIEW, Calif., Feb.
Agreement Provides Pfizer with Access to 23andMe's Research Portal; Companies to Establish New Lupus Research Community in 2015 MOUNTAIN VIEW, Calif., Jan.
- A serpent whose bite was fabled to produce intense thirst.